Amaranth

Key Challenge

Amaranth Medical, Inc: Amaranth was a medical device company which designed & manufactured bioresorbable stents / products for cardiovascular interventions and other nonvascular applications. Onyx executed the negotiated sale of the company & its Singapore based subsidiary Amaranth Medical, PT. Ltd, during an Assignment for the Benefit of Creditors.

Key Takeaway

ONYX prefunded and advanced the budget required to complete the sale process. The sale included substantially all of Amaranth’s assets, including intellectual property (patents, trademarks and clinical data).